Clinical development of TLR agonists as adjuvants: "post-alum adjuvant" candidates may reach beyond their intended purpose.
Green
S J
SJ
D000277:Adjuvants, Pharmaceutic / Q000494:pharmacology*; D000534:Alum Compounds / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D013678:Technology, Pharmaceutical / Q000639:trends; D051193:Toll-Like Receptors / Q000819:agonists* / Q000502:physiology
D000277:Adjuvants, Pharmaceutic; D000534:Alum Compounds; D051193:Toll-Like Receptors; C041524:aluminum sulfate